Medical Research
(H05)
IRS Verified
DX Registered
990 on File
NATIONAL PERT CONSORTIUM INC
Financial strength (30%)
66/100
Reliability (20%)
50/100
Effectiveness (25%)
58/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Mission Statement
Our mission is to enable the best care for pulmonary embolism (PE blood clots) worldwide, ensuring that all individuals, regardless of geographic location or available resources, have access to high-quality care. We achieve this by educating healthcare providers and the public, increasing awareness, disseminating best practices, and empowering providers and patients. Through these efforts, we aim to improve outcomes, reduce disparities, and save lives.
Financial Overview — FY 2023
$2.0M
Total Revenue
$1.8M
Total Expenses
$1.1M
Net Assets
3
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
62.8%
Fundraising Efficiency
562.0%
Operating Reserve
7.74x
Liability-to-Asset
44.7%
Revenue Diversification
98.9%
Executive Compensation
$336K
Compared with Peers
FY 2023
Compared with 481 similar organizations
(United States, Medical Research, $1M–$10M in expenses), FY 2023.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
62.8% | 82.4% |
P10P90
|
Bottom quarter |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
29.7% | 12.0% |
P10P90
|
Bottom quarter |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
7.6% | 1.0% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
562.0% | 135.9% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
7.7 mo | 15.1 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
44.7% | 11.5% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
98.9% | 93.0% |
P10P90
|
Below median |
|
Revenue growth
Year over year revenue growth
|
6.2% | 7.0% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
4.8% | 12.7% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
13.1% | 0.1% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2023 | $2.0M | $1.8M | $1.1M | 62.8% | 3 |
| 2022 | $1.9M | $1.7M | $871K | 57.6% | 5 |
| 2021 | $1.4M | $1.1M | N/A | — | 5 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.